Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer
CXCL2; MegaClust; PD1; Snail; hypoxia; immune exclusion; immunotherapy; lung cancer; neutrophil; vascularization
Lung Neoplasms
QH301-705.5
Neutrophils
[SDV]Life Sciences [q-bio]
Chemokine CXCL2
Programmed Cell Death 1 Receptor
610 Medicine & health
Adenocarcinoma of Lung
Adenocarcinoma
Proto-Oncogene Proteins p21(ras)
Mice
03 medical and health sciences
vascularization
immune exclusion
MegaClust
Animals
Antigens, Ly
Humans
Biology (General)
Mice, Knockout
0303 health sciences
Neovascularization, Pathologic
hypoxia
Gene Expression Profiling
neutrophil
Antibodies, Monoclonal
Sciences bio-médicales et agricoles
CXCL2
Prognosis
3. Good health
[SDV] Life Sciences [q-bio]
PD1
Gene Expression Regulation, Neoplastic
lung cancer
Disease Models, Animal
Snail
Disease Progression
570 Life sciences; biology
immunotherapy
Leukocyte Reduction Procedures
DOI:
10.1016/j.celrep.2017.11.052
Publication Date:
2017-12-12T13:57:38Z
AUTHORS (12)
ABSTRACT
Understanding the immune compartment of tumors facilitates the development of revolutionary new therapies. We used a Kras(G12D)-driven mouse model of lung cancer to establish an immune signature and identified a contribution of Gr1+ neutrophils to disease progression. Depletion experiments showed that Gr1+ cells (1) favor tumor growth, (2) reduce T cell homing and prevent successful anti-PD1 immunotherapy, and (3) alter angiogenesis, leading to hypoxia and sustained Snail expression in lung cancer cells. In turn, Snail accelerated disease progression and increased intratumoral Cxcl2 secretion and neutrophil infiltration. Cxcl2 was produced mainly by neutrophils themselves in response to a factor secreted by Snail-expressing tumor cells. We therefore propose a vicious cycle encompassing neutrophils and Snail to maintain a deleterious tumor microenvironment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (175)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....